Simponi (Golimumab) - Treatment for Ulcerative Colitis (UC)

Simponi (golimumab) is a subcutaneous injection for the treatment of adult patients living with ulcerative colitis (UC). The drug was discovered and developed by Janssen Biotech.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news